Abstract
The brain is a rare site of metastasis in malignant pleural mesothelioma (MPM), and its clinical features and prognosis remain unclear. The aim of this study was to investigate the incidence, prognosis, and risk factors for brain metastases (BM) in MPM patients. Between July 1993 and October 2014, 150 patients with histologically proven MPM were included in this retrospective study. The cumulative incidence of BM was estimated with the Kaplan–Meier method, and differences between groups were analyzed by the log-rank test. Multivariate logistic regression analysis was applied to assess risk factors for BM. The median follow-up time was 11 months (range 0–154.0 months). A total of eight patients (5.3 %) developed BM during the course of their illness. Multivariate analysis identified age <65 years (odds ratio [OR] = 5.83, p = 0.038) and International Mesothelioma Interest Group stage IV (OR = 1.69, p = 0.040) as independent factors related to increased risk of developing BM. The 1-and 2-year cumulative rates of BM were 4.0 % (95 % confidence intervals [CI] 1.4–8.5 %) and 5.3 % (95 % CI 2.3–10.2 %), respectively. Our study showed that the overall survival (OS) of patients with BM was worse than that of patients without BM (median OS 6.5 vs. 11.0 months, p = 0.037). The prognosis for BM in MPM patients is poor. Clinicians should perform careful screening for BM, especially in patients with risk factors.
Similar content being viewed by others
Abbreviations
- MPM:
-
Malignant pleural mesothelioma
- BM:
-
Brain metastasis
- ECOG:
-
Eastern Cooperative Oncology Group
- PS:
-
Performance status
- IMIG:
-
International Mesothelioma Interest Group
- EPS:
-
European Organization for Research and Treatment of Cancer Prognostic Score
- CALGB:
-
Cancer and Leukemia Group B
- MRI:
-
Magnetic resonance imaging
- CT:
-
Computed tomography
- OS:
-
Overall survival
References
Gemba K, Fujimoto N, Kato K, Aoe K, Takeshima Y, Inai K, Kishimoto T (2012) National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci 103:483–490
Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD (2014) A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83:240–245
Wen P, Black P, Loeffler J (2001) Metastatic brain cancer. In: DeVita V, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 2655–2670
Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54
Falconieri G, Grandi G, DiBonito L, Bonifacio-Gori D, Giarelli L (1991) Intracranial metastases from malignant pleural mesothelioma. Report of three autopsy cases and review of the literature. Arch Pathol Lab Med 115:591–595
Chari A, Kolias AG, Allinson K, Santarius T (2015) Cerebral metastasis of a malignant pleural mesothelioma: a case report and review of the literature. Cureus 7:e241. doi:10.7759/cureus.241
Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108:1122–1128
Fennell DA, Parmar A, Shamash J, Evans MT, Sheaff MT, Sylvester R, Dhaliwal K, Gower N, Steele J, Rudd R (2005) Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol 23:184–189
Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113:723–731
Edwards J, Abrams K, Leverment J, Spyt T, Waller D, O’Byrne K (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55:731–735
Miller AC, Miettinen M, Schrump DS, Hassan R (2014) Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review. Ann Am Thorac Soc 11:1075–1081
Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M, Kelsey CR (2010) Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 116:5038–5046. doi:10.1002/cncr.25254
Hsiao SH, Chung CL, Chou YT, Lee HL, Lin SE, Liu HE (2013) Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases. Lung Cancer 82:319–323. doi:10.1016/j.lungcan.2013.08.004
Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR (2015) Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Res Treat 151:225–232. doi:10.1007/s10549-015-3381-8
Frankel TL, Bamboat ZM, Ariyan C, Coit D, Sabel MS, Brady MS (2014) Predicting the development of brain metastases in patients with local/regional melanoma. J Surg Oncol 109:770–774. doi:10.1002/jso.23574
Mansfield AS, Symanowski JT, Peikert T (2014) Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials. Lung Cancer 133–136. doi: 10.1016/j.lungcan.2014.08.017
Finn RS, Brims FJ, Gandhi A, Olsen N, Musk AW, Maskell NA, Lee YC (2012) Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients. Chest 142:1267–1273
Ishikawa T, Wanifuchi H, Abe K, Kato K, Watanabe A, Okada Y (2010) Brain metastasis in malignant pleural mesothelioma presenting as intratumoral hemorrhage. Neurol Med Chir (Tokyo) 50:1027–1030
Colleoni M, Liessi G, Avventi C, Pancheri F, Sgarbossa G, Vicario G, Manente P (1996) Response to chemotherapy of brain metastases from malignant pleural mesothelioma. Tumori 82:456–458
Hooper CE, Morley AJ, Virgo P, Harvey JE, Kahan B, Maskell NA (2013) A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. Eur Respir J 41:18–24
Acknowledgments
This study was supported by “The research and development and the dissemination projects related to the 9 fields of occupational injuries and illnesses” of the Japan Labour Health and Welfare Organization and by grants-in-aid from the Ministry of Health, Labor and Welfare, Japan (150401-02).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study (retrospective), formal consent is not required.
Rights and permissions
About this article
Cite this article
Yamagishi, T., Fujimoto, N., Miyamoto, Y. et al. Brain metastases in malignant pleural mesothelioma. Clin Exp Metastasis 33, 231–237 (2016). https://doi.org/10.1007/s10585-015-9772-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-015-9772-8